Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Agilent to Host Webinars on Food Safety and Quality

Published: Tuesday, March 12, 2013
Last Updated: Tuesday, March 12, 2013
Bookmark and Share
Focus will be on GC/MS, LC/MS, ICP-MS measurement solutions for food adulteration, biotoxins, veterinary drugs and trace metals.

Agilent Technologies Inc. has announced that it will sponsor a series of free educational programs on food safety and quality. In four online events, industry experts Jack Cappozzo, Dr. Philipp Hess, Dr. Thomas Glauner, and Dr. Susan Ebler will share important data from recent studies using Agilent's LC, LC/MS and ICP-MS technologies for food screening and analysis.

The webinars will cover a range of topics: profiling/origin identification of olive oils, metabolic studies of marine biotoxins in shellfish, screening for veterinary drugs, and profiling trace metals in wine.

The webinars will take place at 9 a.m. and again at 1 p.m. EDT on March 12, April 9, May 30 and Oct. 8. Each will also be made available for on-demand replay.

"Today, global food and agriculture industries face increasing demands for faster, more sensitive analytical testing solutions for food authenticity, quality and safety," said John Lee, Agilent's food market manager.

Lee continued, "This webinar series will feature industry experts who are currently using our food testing and analysis technologies in a variety of important applications, and we invite all those who are interested in learning more to attend."

"A hot topic in food testing right now is the adulteration of extra virgin olive oil (EVOO), which has become a major trend worldwide for producers who wish to maximize the commercial value of their counterfeit olive oil products," said Jack Cappozzo, director of chemistry at the Institute for Food Safety and Health, and guest presenter of Agilent's first webinar.

Cappozzo continued, "We have developed a non-targeted Q-TOF LC/MS method for analysis of olive oils that will predict whether oils will meet standardized international classifications for EVOO."

The four seminars are:
Profiling Extra Virgin Olive Oil Using Q-TOF LC/MS and Developing a Prediction Model for Geographical Origin Determination and Adulteration of Oils, Tuesday, March 12: Jack Cappozzo, director of chemistry from the Institute for Food Safety and Health, Illinois, will describe a study to develop a Q-TOF LC/MS method for analysis of olive oils, to classify oils of different origin using PCA (principal component analysis), and to create a sample class prediction model for predicting unknown samples into their correct groups.

Target Quantitation and Metabolic Studies of Marine Biotoxins in Shellfish Using Q-TOF Technology, Tuesday, April 9: Dr. Philipp Hess, from the Universite de Nantes, will discuss new LC-HRMS methods used to identify and quantify marine biotoxins in shellfish and marine environmental samples.

Screening, Identification and Quantitation of Veterinary Drugs by LC/QQQ and LC/Q-TOF, Thursday, May 30: Dr. Thomas Glauner, LC/MS food segment scientist of Agilent, will discuss how Agilent's QQQ MS/MS, Q-TOF MS/MS, and UHPLC separation technologies enable the sensitive detection of several classes of veterinary drugs in one analytical run.

Uses of Profiling Trace Metal Composition of Wine by ICP-MS and Mass Profiler Professional in the Wine Industry, Tuesday, Oct. 8: Dr. Susan Ebler from the University of California at Davis will present.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent Awards Influential Clinical Genomics Researcher
Dr. Peter Robinson recognized for contributions to clinical genomics and computational biology.
Tuesday, November 29, 2016
Agilent, PureHoney Partner to Develop New Applications for RapidFire/MS System
Companies to further develop the Agilent RapidFire/MS System, and independently create new workflows for pharma, biopharma, forensic toxicology, and metabolomics analysis.
Tuesday, November 01, 2016
Influential Cancer Researcher Receives Agilent Thought Leader Award
Biologist Scott Lowe receives award in recognition for his contributions to cancer biology.
Thursday, October 27, 2016
Agilent’s Non-Small Cell Lung Cancer Companion Dx Receives Expanded FDA Approval
Agilent’s Dako PD-L1 IHC 22C3 pharmDx has an expanded label approved by the U.S. FDA for use in determining PD-L1 expression status to inform treatment in metastatic non-small cell lung cancer with KEYTRUDA® (pembrolizumab).
Tuesday, October 25, 2016
Agilent, Burning Rock Sign Agreement on Molecular Diagnostics
Companies collaborate in their aim to accelerate accurate diagnosis of cancer for patients in China.
Thursday, September 29, 2016
Impact of Emerging Contaminants in Our Water Supply
Emerging contaminants, any synthetic or naturally occurring chemical not commonly monitored in the environment, in our water supply are becoming of increasing concern due to their potential ecological and/or human health effects.
Friday, September 16, 2016
Agilent Technologies to Build New Facility in Colorado
Agilent buys 20 acres in Weld County to increase pharmaceutical manufacturing capacity.
Wednesday, August 10, 2016
Dako Announces CE Mark for Companion Diagnostic
Dako has announced the CE Mark certification for use of PD-L1, a companion diagnostic to Merck's anti-PD-1 immunotherapy Keytruda.
Thursday, August 04, 2016
Agilent to Acquire iLab Solutions
Companies have announced they have signed a definitive agreement under which Agilent will acquire substantially all of the assets of iLab, the market leader in cloud-based solutions for core laboratory management.
Wednesday, June 29, 2016
Agilent, Eurofins Genomics Collaborate
Agilent plans to offer custom components and an assembled plasmid service for Agilent’s SureVector next-generation cloning kits through a collaboration with Eurofins.
Monday, March 14, 2016
Best Practices for Breast Cancer Diagnosis
Agilent has published “Breast Cancer Diagnosis: Past, Present and Future,” a white paper on the use of immunohistochemistry in diagnosing and treating breast cancer.
Monday, March 14, 2016
Agilent Invests $80M in Lasergen
Company has announced that it has invested $80 million in Lasergen, with innovative next-generation sequencing technology for clinical applications.
Friday, March 11, 2016
Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics
Company has announced a program that gives biologists conducting functional genomics research early access to a potential new resource.
Saturday, February 13, 2016
Agilent Technologies and 10x Genomics Announce Collaboration
Company has announced collaboration to develop a premium exome that provides a streamlined workflow for 10x Genomics'Chromium platform.
Friday, February 12, 2016
Agilent Wins Award for Innovation in LC
Dual-needle technology enhances speed, flexibility.
Thursday, January 28, 2016
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Diabetes Missing Link Discovered
Researchers from the University of Auckland have shown that beta catenin plays a vital role in the control of insulin release from the pancreas.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
Biological Link between the Gut Microbiome and Parkinson’s Disease
The findings suggest that targeting the gut microbiome may provide a new approach for diagnosing and treating Parkinson’s disease.
How the Brain Recognizes Faces
Machine-learning system spontaneously reproduces aspects of human neurology.
Boosting Effectiveness of Asthma Therapy
A team of scientists from UCSF has developed a new treatment to dampen bronchospasm.
Improved Stability, Shelf Life of Protein Drugs
Study improves protein drug stability and extend their shelf life by tested a novel route for non-covalent protein modification.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!